Profitability

Miscellaneous

Novartis (NYSE:NVS) Frequently Asked Questions

What is Novartis' stock symbol?

Novartis trades on the New York Stock Exchange (NYSE) under the ticker symbol "NVS."

How will Novartis' stock buyback program work?

Novartis declared that its Board of Directors has initiated a stock buyback program on Saturday, April 8th 2017, which allows the company to buyback $5,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to repurchase up to 2.9% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board of directors believes its shares are undervalued.

How were Novartis' earnings last quarter?

Novartis AG (NYSE:NVS) announced its quarterly earnings results on Thursday, April, 19th. The company reported $1.28 earnings per share for the quarter, topping the consensus estimate of $1.25 by $0.03. The firm had revenue of $12.69 billion for the quarter, compared to analysts' expectations of $12.45 billion. Novartis had a net margin of 16.04% and a return on equity of 16.23%. Novartis's revenue was up 10.0% compared to the same quarter last year. During the same period last year, the company earned $1.13 earnings per share. View Novartis' Earnings History.

When is Novartis' next earnings date?

What price target have analysts set for NVS?

10 equities research analysts have issued 1 year price objectives for Novartis' stock. Their forecasts range from $82.25 to $91.00. On average, they expect Novartis' stock price to reach $87.75 in the next twelve months. View Analyst Ratings for Novartis.

Has Novartis been receiving favorable news coverage?

Media headlines about NVS stock have been trending somewhat positive this week, Accern Sentiment reports. The research firm scores the sentiment of press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Novartis earned a coverage optimism score of 0.15 on Accern's scale. They also assigned media coverage about the company an impact score of 47.56 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near future.

How do I buy shares of Novartis?

Shares of NVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Novartis' stock price today?

One share of NVS stock can currently be purchased for approximately $76.09.

How big of a company is Novartis?

Novartis has a market capitalization of $178.07 billion and generates $49.11 billion in revenue each year. The company earns $7.70 billion in net income (profit) each year or $4.81 on an earnings per share basis. Novartis employs 121,597 workers across the globe.

How can I contact Novartis?

Novartis' mailing address is LICHTSTRASSE 35, BASEL V8, CH 4056. The company can be reached via phone at 41-61-324-1111 or via email at [email protected]

MarketBeat Community Rating for Novartis (NVS)

MarketBeat's community ratings are surveys of what our community members think about Novartis and other stocks. Vote "Outperform" if you believe NVS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Novartis (NYSE:NVS) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

10 Wall Street analysts have issued ratings and price targets for Novartis in the last 12 months. Their average twelve-month price target is $87.75, suggesting that the stock has a possible upside of 15.19%. The high price target for NVS is $91.00 and the low price target for NVS is $82.25. There are currently 3 sell ratings, 6 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."

Dividends

Novartis (NYSE:NVS) Dividend Information

Novartis pays an annual dividend of $1.91 per share, with a dividend yield of 2.51%. NVS's most recent annual dividend payment was Friday, March 3. Novartis pays out 39.71% of its earnings out as a dividend.